Common Neurological Disorders

Regeneron Pharmaceuticals Inc. and Intellia Therapeutics Inc. have announced an expanded research collaboration intended to develop additional CRISPR-based gene editing therapies focused on neurological and muscular diseases.

CHICAGO — Persistent neurocognitive impairment, depression and anxiety were frequently reported in individuals with mild COVID-19 infection in Lima, Peru, according to a poster at ANA 2022.

Noncommunicable neurological disorders resulted in “a large and increasing burden” in the United States, according to a systematic analysis of the Global Burden of Disease study from 2017 that was published in JAMA Neurology.